Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users' SummitBusiness Wire • 04/11/24
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial OutlookBusiness Wire • 03/21/24
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024Business Wire • 03/04/24
Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific MeetingBusiness Wire • 02/21/24
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the BodyBusiness Wire • 01/22/24
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue ResultsBusiness Wire • 01/08/24
Apyx Medical Corporation Announces New Debt Facility with Perceptive AdvisorsBusiness Wire • 11/09/23
Apyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial OutlookBusiness Wire • 11/09/23
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in NovemberBusiness Wire • 11/07/23
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023Business Wire • 10/02/23
Apyx Medical Corporation Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial OutlookBusiness Wire • 08/10/23
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2023 Financial Results on August 10, 2023Business Wire • 06/29/23
Apyx Medical Corporation Announces FDA 510(k) Clearance for the Renuvion® Micro HandpieceBusiness Wire • 06/14/23
Is Apyx Medical (APYX) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 05/16/23
Apyx Medical Corporation Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial OutlookBusiness Wire • 05/11/23
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body ContouringBusiness Wire • 04/28/23